FDA Accepts Nanoscope`s BLA for Optogenetic Gene Therapy Mogenry in Retinitis Pigmentosa
The FDA has accepted and filed Nanoscope Therapeutics’ biologics license application (BLA) for Mogenry (sonpiretigene isteparvovec; MCO-010), an investigational optogenetic gene therapy designed to restore vision in patients with retinitis pigmentosa (RP) and severe vision loss.
Source: eyewire
Could this common bacteria in the eye be driving Alzheimer's disease?
A new study found that a common type of bacteria that causes sinus infections may stay in the eye for many years, potentially increasing a person’s risk for developing Alzheimer’s disease. Scientists believe the identification of these bacteria may help detect and develop new treatment options for Alzheimer’s disease.
Source: Medical News Today
Aging blocks the retina's ability to regrow lost neurons, a first-of-its-kind study finds
A new study from the laboratory of Levi Todd, Ph.D., at Upstate Medical University has found that aging significantly limits the ability of support cells in the retina, called glia, to be reprogrammed into new neurons, a finding with important implications for the future of regenerative medicine for age-related neurodegenerative diseases such as Alzheimer's, Parkinson's and glaucoma.
Source: Medical Xpress
Early surgery for bacterial eye infection offers hope to patients
Early vitrectomy surgery for acute endophthalmitis, a rare eye condition, may potentially benefit patients' vision more than the current antibiotic-first approach, according to a study led by researchers at University College London (UCL) and Moorfields Eye Hospital.
Source: Medical Xpress
Virtual reality-based digital defocus vision training may aid myopia in children
Virtual reality-based digital defocus vision training (DDVT) may be a promising adjunctive approach for pediatric myopia control, according to a study published online Aug. 27 in JAMA Ophthalmology.
Source: Medical Xpress
Clear Eyes eye drops recalled nationwide over sterility concerns
Nearly 40,000 bottles of a widely sold eye drop are being pulled from shelves nationwide because the maker cannot guarantee the product is sterile.
Source: Medical Xpress
Portable eye exam equipment aims to reduce barriers in rural health care
Around 75% of American adults need vision correction, but access to eye care remains uneven, particularly in rural communities and for patients with mobility limitations. To help close those gaps, Dr. Nick Panzo and Dr. Hamza Memon, Texas A&M University School of Engineering Medicine (EnMed) graduates, are developing portable eye exam equipment about the size of a virtual reality headset. The device is designed to make comprehensive eye exams more accessible by bringing a key piece of ophthalmology equipment out of clinics and into a wider range of health care settings.
Source: Medical Xpress
Researchers Develop Diagnostic Model to Detect COVID-Related Eye Problems
Mild COVID-19 can cause severe and long-lasting eye problems, according to a study from Link?ping University, Sweden. The study also explains why it has been difficult for sufferers to get help: The abnormal eye behavior cannot be detected by standard methods. The researchers have developed a diagnostic model to detect COVID-related eye problems.
Source: Medical Xpress
Researchers Discover the Eye`s Hidden Cleanup System
Many of the world`s leading causes of irreversible blindness, including glaucoma and age-related macular degeneration, share a common problem: the buildup of fluid, waste and inflammatory debris in the back of the eye.
Source: Medical Xpress
Daylight Saving Time May Leave a Surprising Trace in the Eye`s Smallest Blood Vessels Each Spring
For the first time, Northwestern Medicine scientists have detailed how fall and spring daylight saving time transitions affect a person`s risk of developing retinal vascular disease. The study is published in Scientific Reports.
Source: Medical Xpress